Healthy adults
Conditions
Interventions
None listed
Sponsors
Kao Corporation
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1.Panelists who are female and Caucasian with their ages from 18 to 45 years old. Panelists with normal or combined oily and dry facial skin according to their self-assessments 2.Panelists who are willing to avoid sun exposure, tanning beds, sunless tanners, and skin lightening products on their faces from the day two weeks prior to the study to the day when the study completes. 3.Panelists who agree to follow their typical daily routines and refrain from starting any new activities while participating in the study (e.g. swimming, tanning bed usage, exercising, sunbathing). 4.Panelists who agree to follow their typical facial care routines and agree not to switch or try any new facial products or make-ups from the day two weeks prior to the study to the day when the study completes. 5.Panelists who agree to refrain from using any supplements OTC or prescription medications, especially for sebum regulation, anti-bacteria, and anti-inflammation from the day two weeks prior to the study to the day when the study completes. 6.Panelists who are willing to wash their faces not to apply any cosmetics at the night before each lab visit and refrain from applying any facial moisturizers, facial products, or make-ups on their faces at the morning immediately before the lab visits. 7.Panelists who agree to participate in the study after understanding the possible risks and benefits during this study and signing the informed consent form. 8.Panelists who are willing to have photographs and measurements taken on their faces. 9.Panelists who are willing to attend the repetitive two days.
Exclusion criteria
Exclusion criteria: 1.Panelists who have very or extremely sensitive skins on their faces. Panelists who have a known allergy or sensitivity to any facial care product, facial cleanser, or to any specific ingredient or fragrance used in these types of products 2.Panelists having illnesses or diseases which, in the opinion of the investigator, might interfere with the conduct of the study or the interpretation of results. Panelists with any skin irritation, skin condition (such as rosacea, eczema, atopic dermatitis, or psoriasis), or severe acne on their faces 3.Panelists who take a prescription or OTC medication which, in the opinion of the investigator, might interfere with the conduct of the study or the interpretation of results. 4.Panelists who have used a topical or oral antibiotic on their faces in the last two weeks. 5.Panelists under the care of a doctor or dermatologist for facial skin issues or taking prescription medication (topical or oral) for any facial skin issues. 6.Panelists who have started any types of estrogen or hormone therapies (including birth control pills) within four weeks prior to the study implementation and/or are planning to start aforementioned therapies during the study. Panelists who are pregnant or breastfeeding or are planning to be pregnant. 7.Panelists who have undergone a sort of chemical peeling on their faces in the last six months. 8.Panelists who have undergone a sort of laser therapy on their faces in the last six months. 9.Panelists currently participating in, or scheduled to participate in, another facial study during the study period. 10.Panelists who have used a pore strip on their faces within two weeks prior to the study implementation. 11.Panelists who work for, or have household members who work for, a manufacturer or an advertiser of personal care products.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the amount of sebum secretion, sebum composition, gene expressions, protein expressions, skin flora, skin color, dermatological assessment and skin moisture content | — |
Countries
North America
Contacts
Public ContactArisa Kato
Kao Corporation R&D -Core Technology- Biological Science Research
Outcome results
None listed